Loading...

Becton, Dickinson and Company

BDXBNYSE
Healthcare
Medical - Instruments & Supplies
$48.16
$0.66(1.39%)

Becton, Dickinson and Company (BDXB) Stock Competitors & Peer Comparison

See (BDXB) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BDXB$48.16+1.39%13.7B7.60$6.33+2.19%
ISRG$495.86+1.48%177.7B69.06$7.18N/A
BDX$185.32+0.92%53.1B35.93$5.16+2.19%
BDXA$59.24-2.24%48.7B21.44$2.76+2.19%
ALC$91.86-0.04%45.4B40.83$2.25+0.36%
RMD$275.16+0.61%40.4B30.86$8.92+0.77%
WST$263.51-5.59%18.9B39.48$6.67+0.31%
BAX$29.22+1.56%15B-56.19-$0.52+2.73%
COO$74.59+1.07%14.9B36.03$2.07N/A
HOLX$66.50+0.61%14.8B27.94$2.38N/A
Showing 1 to 10 of 75 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BDXB vs ISRG Comparison July 2025

BDXB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BDXB stands at 13.7B. In comparison, ISRG has a market cap of 177.7B. Regarding current trading prices, BDXB is priced at $48.16, while ISRG trades at $495.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BDXB currently has a P/E ratio of 7.60, whereas ISRG's P/E ratio is 69.06. In terms of profitability, BDXB's ROE is +0.06%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, BDXB is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for BDXB.Check ISRG's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;